Corporate Responsibility Report

Overview

The report is Acadia Pharmaceuticals' inaugural comprehensive Corporate Responsibility disclosure for 2025. It covers people, communities, patients and products, environmental stewardship, data privacy, and compliance and ethics. The company reports approximately 800 employees and 50% women on its Board. It also describes Board oversight of climate risks, a GHG inventory following the GHG Protocol, and plans to develop Scope 1, Scope 2 and future Scope 3 reporting.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: Ends 31 December 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services